MarketPulse

denifanstat

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sagimet Biosciences Names Veteran Pharma Executive Andreas Grauer as CMO

Sagimet Biosciences appoints Dr. Andreas Grauer as Chief Medical Officer, replacing retiring Dr. Eduardo Martins. Grauer joins from senior roles at Amgen and Corcept, receiving $1.34M in stock options.
AMGNSGMTOMERexecutive leadershipstock option grant
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sagimet Biosciences Unveils MASH Trial Data, Secures Nasdaq Approval for Employee Equity Grant

Sagimet presented Phase 2b denifanstat data showing bile acid biomarker potential in MASH patients, while securing Nasdaq approval for employee stock options.
SGMTclinical trial dataMASH